Juvéderm® Voluma XC is the first FDA-approved injectable gel, made to quickly add volume to your face's cheek area. This gel has the ability to correct age-related volume loss in adults over the age of 21. Juvéderm® Voluma XC can provide a subtle lift and contour for up to two years, depending on the type of treatment involved.



Is volume loss in the cheeks making you look older?

As you age, it's not just about lines and wrinkles. Your cheeks also lose volume and the skin may sag. That's why a more youthful profile starts with the apples of your cheeks.


First and only FDA-approved injectable gel for the cheek area

How it works

Juvéderm® Voluma XC is injected under the skin using a fine needle. It can instantly add just enough volume to gently lift the cheek area. To reduce discomfort during the procedure, Juvéderm® Voluma XC contains an anesthetic called lidocaine.  

What are the possible side effects?

Side effects are moderate (uncomfortable) and generally last between 2 to 4 weeks. The most common side effects include temporary reactions at the treatment site such as tenderness. swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Do not use if you have a history of severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to the proteins (gram-positive bacterial proteins) used to make the hyaluronic acid (HA) in Juvéderm® Voluma XC.

JUVÉDERM® XC Professional Full ISI
JUVÉDERM® Ultra XC and JUVÉDERM® XC Important Information

JUVÉDERM® Ultra XC injectable gel is indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21.

JUVÉDERM® XC injectable gels (JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC) are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).


These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to gram-positive bacterial proteins or lidocaine contained in these products.

Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur.
Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled

In order to minimize the risk of potential complications, JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC injectable gels should only be used by healthcare professionals who have appropriate training, experience, and knowledge of facial anatomy
Healthcare professionals are encouraged to discuss the potential risks of soft-tissue injections with their patients prior to treatment and ensure that patients are aware of signs and symptoms of potential complications
153254 APC81XM15
The safety and effectiveness for the treatment of anatomic regions other than moderate to severe facial wrinkles and folds with JUVÉDERM® XC, and the lips and perioral area for lip augmentation with JUVÉDERM® Ultra XC, have not been established in controlled clinical studies
As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials
The safety for use during pregnancy, in breastfeeding females, and in patients under 18 years has not been established
The safety in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied
Use with caution in patients on immunosuppressive therapy
Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites

The most commonly reported side effects are temporary injection-site redness, swelling, pain/tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. Most side effects are mild or moderate in nature, lasting 14 days or less. 
To report a problem with JUVÉDERM® Ultra XC or JUVÉDERM® Ultra Plus XC, please call Allergan Product Surveillance at 1-800-624-4261.

For more information, please see JuvedermDFU.com or call the Allergan Medical Information line at 1-800-433-8871.

JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC injectable gels are available by prescription only.

  • Adds volume lost to aging for adults over 21 years
  • Creates contour and a subtle lift instantly
  • Helps restore a more youthful profile for up to 2 years with optimal treatment
  • Provides natural-looking results
  • Is a non-surgical treatment
  • Contains modified hyaluronic acid (HA) made from a naturally occurring complex sugar

Juvéderm® XC

Over time, your skin loses elasticity and moisture. This natural process, plus genetics and environmental factors like sun exposure, can cause moderate to severe lines and folds such as parentheses, vertical lip, corner, and marionette lines to form around the nose and mouth. While serums and creams can help moisturize the skin’s surface, JUVÉDERM® XC goes beneath the surface to reduce the appearance of deep lines and folds, and give you the natural-looking, long-lasting results you want.


JUVÉDERM® XC is a nonsurgical treatment and is the only HA filler proven to last up to 1 year in moderate to severe facial wrinkles and lines.

Juvéderm® Ultra XC


Whether you’ve noticed your lips thinning over time, or simply want fuller lips, JUVÉDERM® Ultra XC can give you the natural-looking, long-lasting results you desire.

JUVÉDERM® Ultra XC adds fullness to lips.

  • Instant, natural-looking results
  • Nonsurgical treatment
  • The first filler proven to last up to 1 year in the lips*

Juvéderm® Volbella XC

Whether you may want to add subtle volume to your lips or soften the appearance of the vertical lines above the, Juvéderm® Volbella XC is the first and only FDA-approved filler proven to increase lip fullness and soften the appearance of vertical lip lines for up to 1 year with optimal treatment.

Juvéderm® Volbella XC may be right for you if:

  • You would like to add subtle volume to your lips
  • You would like to soften the appearance of vertical lip lines
  • You want natural-looking, long-lasting results